Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats

Phillip Ryan,Adesola Odunayo,Josh Price,Silke Hecht,Shanna Hillsman,Gina Galyon,Joerg Steiner,M. Katherine Tolbert
DOI: https://doi.org/10.1111/jvim.15887
2020-09-01
Journal of Veterinary Internal Medicine
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Proton pump inhibitors (PPIs) are among the most commonly prescribed medications for esophagitis and upper gastrointestinal erosion and ulceration in cats. Newer PPIs such as lansoprazole and esomeprazole are believed to be effective in cats, but the effect of many of these PPIs on gastric pH in cats has not been explored.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Hypothesis/Objectives</h3><p>To evaluate the efficacy of PO esomeprazole, dexlansoprazole, and lansoprazole on intragastric pH in healthy cats. We hypothesized that esomeprazole and lansoprazole would provide superior acid suppression compared to dexlansoprazole and reach pH goals extrapolated from people for the treatment of esophagitis and duodenal ulceration.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Animals</h3><p>Twelve healthy research cats.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Randomized, 3‐way crossover study. Cats were given esomeprazole and lansoprazole at a dosage of 1 mg/kg PO q12h or dexlansoprazole at 6 mg/kg PO q12h. Intragastric pH was recorded at baseline and for 4 days of treatment. Mean pH and the mean percentage time (MPT) intragastric pH was ≥3 or ≥4 were compared among and within treatment groups.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Cats treated with lansoprazole had a lower MPT ± SD of intragastric pH ≥3 (8.8 ± 6.8%) and mean ± SD pH (1.6 ± 0.5) than did cats treated with dexlansoprazole (41.2 ± 34.6% and 3.11 ± 1.6, respectively) or esomeprazole (54 ± 33.8% and 4.1 ± 3.9, respectively;<i>P</i> ≤ .04). Esomeprazole was the only treatment that achieved the goals defined for people for the treatment of duodenal ulceration by Day 4 of treatment (MPT ± SD of intragastric pH ≥4 of 77.1 ± 29.2%). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions and Clinical Importance</h3><p>Orally administered esomeprazole might be a superior acid suppressant in cats compared to PO lansoprazole or dexlansoprazole.</p></section>
veterinary sciences
What problem does this paper attempt to address?